Abstract: Multiple parallel sparse linear arrays (MPSLAs) can be strategically deployed in two-dimensional (2D) or three-dimensional (3D) space, offering a unique advantage by enabling easy conformal ...

Can you trust everything you see online? As AI-generated images grow more advanced, distinguishing between authentic visuals and artificial creations has become increasingly challenging. From ...

The US military has activated its first-ever one-way attack squadron, operating a derivative of Iran’s prolific Shahed-136 kamikaze drone. US Central Command (CENTCOM) revealed the creation of the new ...

Under the category of careers that are, or will be, impacted, by artificial intelligence, attorneys are inevitably on it. Here’s a tale of a lawyer caught using AI while explaining to the Court why he ...

The Environmental Protection Agency (EPA) is looking to roll back regulatory standards for three types of per- and polyfluoroalkyl substances, also known as PFAS chemicals, in drinking water systems.

Community driven content discussing all aspects of software development from DevOps to design patterns. The speed and efficiency of traditionally developed software applications is limited by the fact ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

Investors considering a purchase of Array Technologies Inc (Symbol: ARRY) stock, but tentative about paying the going market price of $7.12/share, might benefit from considering selling puts among the ...

President Trump is pulling a “reverse Nixon” and putting a wedge between Russia and China after his predecessor “drove” Beijing and Moscow together, US Chief of Protocol Monica Crowley explained in ...

A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...

Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...